These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9359021)

  • 1. Drug therapy for obesity in the elderly.
    Dvorak R; Starling RD; Callés-Escandon J; Sims EA; Poehlman ET
    Drugs Aging; 1997 Nov; 11(5):338-51. PubMed ID: 9359021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A; Lundsgaard C
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in the pharmacological management of obesity.
    Carek PJ; Dickerson LM
    Drugs; 1999 Jun; 57(6):883-904. PubMed ID: 10400403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and pharmacologic treatment of obesity: the role of energy regulatory mechanism.
    Manulu MS; Sutanegara IN
    Acta Med Indones; 2006; 38(1):42-50. PubMed ID: 16479031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benefit-risk assessment of sibutramine in the management of obesity.
    Nisoli E; Carruba MO
    Drug Saf; 2003; 26(14):1027-48. PubMed ID: 14583064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches for the treatment of obesity.
    Fernández-López JA; Remesar X; Foz M; Alemany M
    Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacotherapy of obesity].
    Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
    Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-obesity drugs: use, mechanisms and clinical importance.
    Adam O; Forth W
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacologic approach to the treatment of obesity.
    Weiser M; Frishman WH; Michaelson MD; Abdeen MA
    J Clin Pharmacol; 1997 Jun; 37(6):453-73. PubMed ID: 9208352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiobesity therapy: emerging drugs and targets.
    Das SK; Chakrabarti R
    Curr Med Chem; 2006; 13(12):1429-60. PubMed ID: 16719787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of metabolic parameters by energy deficit and hunger.
    Kitka T; Tuza S; Varga B; Horváth C; Kovács P
    Metabolism; 2015 Oct; 64(10):1235-9. PubMed ID: 26209349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for obesity.
    Ioannides-Demos LL; Proietto J; McNeil JJ
    Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes.
    Horowitz M; Flint A; Jones KL; Hindsberger C; Rasmussen MF; Kapitza C; Doran S; Jax T; Zdravkovic M; Chapman IM
    Diabetes Res Clin Pract; 2012 Aug; 97(2):258-66. PubMed ID: 22446097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF; Wauters MA; De Leeuw IH
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of obesity.
    Berke EM; Morden NE
    Am Fam Physician; 2000 Jul; 62(2):419-26. PubMed ID: 10929704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The harmfulness of drugs and slimming substances--a toxicologist's point of view].
    Kujawa A; Szponar J; Szponar E; Zapalska-Pozarowska K; Kostek H
    Przegl Lek; 2012; 69(8):548-51. PubMed ID: 23243925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary manipulation on substrate flux and energy balance in obese women taking the appetite suppressant dexfenfluramine.
    Poppitt SD; Swann DL; Murgatroyd PR; Elia M; McDevitt RM; Prentice AM
    Am J Clin Nutr; 1998 Nov; 68(5):1012-21. PubMed ID: 9808216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.